United States Pharmaceutical Logistics Market Forecast 2024-2032

The United States pharmaceutical logistics market is predicted to develop at a CAGR of 7.62% during the forecast period 2024-2032. Diverse enablers stimulate market growth, like the rising need for temperature-controlled solutions in pharmaceuticals, the expansion of ocean freight services in the pharmaceutical industry, the rise in consumer preference for over-the-counter medicines, and the surge in pharmaceutical logistics during the United States COVID-19 pandemic.

MARKET INSIGHTS

The United States pharmaceutical logistics market is undergoing transitions, with infectious diseases emerging as the leading therapy area, commanding a significant market share. This trend reflects the increasing focus on addressing infectious diseases, which has intensified in recent years due to global health concerns and the ongoing pandemic. Pharmaceutical logistics providers are adapting to meet the demands of this sector, ensuring efficient and timely delivery of medications and vaccines critical to combating infectious diseases.

Within the pharmaceutical logistics landscape, cold chain logistics has emerged as the fastest-growing type. This growth is driven by the need to maintain the integrity and efficacy of temperature-sensitive pharmaceutical products, including vaccines, biologics, and specialty drugs. Cold chain logistics solutions play a vital role in ensuring that these products remain within specified temperature ranges throughout the supply chain, from manufacturing to distribution to end-user delivery.

Furthermore, there is an eminent trend towards increased monitoring of pharmaceutical logistics operations. Stakeholders across the industry are placing greater emphasis on real-time tracking, visibility, and quality control measures. This heightened focus on monitoring aims to enhance efficiency, reduce risks associated with product spoilage or loss, and ensure compliance with regulatory requirements. As pharmaceutical logistics operations become more complex and globally interconnected, robust monitoring systems are becoming integral to optimizing supply chain performance and ensuring product safety and efficacy.

COMPETITIVE INSIGHTS

Some of the major companies in the United States pharmaceutical logistics market include Agility Logistics, Cardinal Health, Cencora (AmerisourceBergen), CEVA Logistics, etc.

Our report offerings include:

Explore key findings of the overall market
Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
Market Segmentation caters to a thorough assessment of key segments with their market estimations
Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
The competitive landscape is the theoretical explanation of the key companies based on factors such as market share.
Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Product Code: 85226

1. RESEARCH SCOPE & METHODOLOGY

1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

2.1. MARKET SIZE & ESTIMATES
2.2. COUNTRY SNAPSHOT
2.3. COUNTRY ANALYSIS
2.4. SCOPE OF STUDY
2.5. CRISIS SCENARIO ANALYSIS
2.6. MAJOR MARKET FINDINGS
- 2.6.1. BRANDED DRUGS ARE THE MOST COMMONLY USED PRODUCTS IN THE PHARMACEUTICAL LOGISTICS MARKET
- 2.6.2. COMMUNICABLE DISEASES HOLD THE LARGEST MARKET SHARE IN THE THERAPY AREA
- 2.6.3. COLD CHAIN LOGISTICS IS THE FASTEST-GROWING TYPE WITHIN THE PHARMACEUTICAL LOGISTICS MARKET
- 2.6.4. MONITORING OF PHARMACEUTICAL LOGISTICS OPERATIONS IS INCREASINGLY BECOMING A FOCUS AREA

3. MARKET DYNAMICS

3.1. KEY DRIVERS
- 3.1.1. RISING NEED FOR TEMPERATURE-CONTROLLED SOLUTIONS IN PHARMACEUTICALS
- 3.1.2. EXPANSION OF OCEAN FREIGHT SERVICES IN PHARMACEUTICAL INDUSTRY
- 3.1.3. RISE IN CONSUMER PREFERENCE FOR OVER-THE-COUNTER MEDICINES
- 3.1.4. SURGE IN PHARMACEUTICAL LOGISTICS DURING THE UNITED STATES COVID-19 PANDEMIC
3.2. KEY RESTRAINTS
- 3.2.1. RIGOROUS REGULATORY REQUIREMENTS IN PHARMACEUTICAL LOGISTICS
- 3.2.2. ENSURING REAL-TIME TRANSPARENCY AND RELIABILITY IN PHARMACEUTICAL LOGISTICS

4. KEY ANALYTICS

4.1. KEY MARKET TRENDS
- 4.1.1. SURGE IN DEMAND FOR CELL & GENE THERAPY LOGISTICS
- 4.1.2. REVOLUTIONIZING PHARMACEUTICAL LOGISTICS THROUGH DIGITAL TRANSFORMATION
- 4.1.3. INCREASING CLINICAL TRIALS LOGISTICS DEMANDS
4.2. PORTER'S FIVE FORCES ANALYSIS
- 4.2.1. BUYERS POWER
- 4.2.2. SUPPLIERS POWER
- 4.2.3. SUBSTITUTION
- 4.2.4. NEW ENTRANTS
- 4.2.5. INDUSTRY RIVALRY
4.3. GROWTH PROSPECT MAPPING
- 4.3.1. GROWTH PROSPECT MAPPING FOR UNITED STATES
4.4. MARKET CONCENTRATION ANALYSIS
4.5. VALUE CHAIN ANALYSIS
- 4.5.1. MANUFACTURING
- 4.5.2. STORAGE
- 4.5.3. TRANSPORTATION
- 4.5.4. DISTRIBUTION
- 4.5.5. MONITORING COMPONENTS
- 4.5.6. CONSUMPTION
4.6. KEY BUYING CRITERIA
- 4.6.1. TYPE OF LOGISTICS
- 4.6.2. SERVICES OFFERED
- 4.6.3. MODE OF TRANSPORTATION
- 4.6.4. APPLICATION
- 4.6.5. REGULATORY COMPLIANCE
- 4.6.6. TECHNOLOGICAL CAPABILITIES
- 4.6.7. COST
- 4.6.8. RELIABILITY
- 4.6.9. AGILITY

5. MARKET BY PRODUCT

5.1. BRANDED DRUGS
- 5.1.1. MARKET FORECAST FIGURE
- 5.1.2. SEGMENT ANALYSIS
5.2. GENERIC DRUGS
- 5.2.1. MARKET FORECAST FIGURE
- 5.2.2. SEGMENT ANALYSIS
5.3. OTC
- 5.3.1. MARKET FORECAST FIGURE
- 5.3.2. SEGMENT ANALYSIS

6. MARKET BY THERAPY AREA

6.1. COMMUNICABLE DISEASES
- 6.1.1. MARKET FORECAST FIGURE
- 6.1.2. SEGMENT ANALYSIS
6.2. ONCOLOGY
- 6.2.1. MARKET FORECAST FIGURE
- 6.2.2. SEGMENT ANALYSIS
6.3. DIABETES
- 6.3.1. MARKET FORECAST FIGURE
- 6.3.2. SEGMENT ANALYSIS
6.4. CARDIOVASCULAR DISEASES
- 6.4.1. MARKET FORECAST FIGURE
- 6.4.2. SEGMENT ANALYSIS
6.5. AUTOIMMUNE DISEASES
- 6.5.1. MARKET FORECAST FIGURE
- 6.5.2. SEGMENT ANALYSIS
6.6. NEUROLOGICAL DISORDERS
- 6.6.1. MARKET FORECAST FIGURE
- 6.6.2. SEGMENT ANALYSIS
6.7. PAIN MANAGEMENT
- 6.7.1. MARKET FORECAST FIGURE
- 6.7.2. SEGMENT ANALYSIS
6.8. RESPIRATORY DISEASES
- 6.8.1. MARKET FORECAST FIGURE
- 6.8.2. SEGMENT ANALYSIS
6.9. OTHER THERAPY AREAS
- 6.9.1. MARKET FORECAST FIGURE
- 6.9.2. SEGMENT ANALYSIS

7. MARKET BY TYPE

7.1. NON-COLD CHAIN LOGISTICS
- 7.1.1. MARKET FORECAST FIGURE
- 7.1.2. SEGMENT ANALYSIS
7.2. COLD CHAIN LOGISTICS
- 7.2.1. MARKET FORECAST FIGURE
- 7.2.2. SEGMENT ANALYSIS

8. MARKET BY COMPONENT

8.1. STORAGE
- 8.1.1. WAREHOUSE
  - 8.1.1.1. MARKET FORECAST FIGURE
  - 8.1.1.2. SEGMENT ANALYSIS
- 8.1.2. REFRIGERATED CONTAINERS
  - 8.1.2.1. MARKET FORECAST FIGURE
  - 8.1.2.2. SEGMENT ANALYSIS
8.2. TRANSPORTATION
- 8.2.1. OVERLAND LOGISTICS
  - 8.2.1.1. MARKET FORECAST FIGURE
  - 8.2.1.2. SEGMENT ANALYSIS
- 8.2.2. SEA FREIGHT LOGISTICS
  - 8.2.2.1. MARKET FORECAST FIGURE
  - 8.2.2.2. SEGMENT ANALYSIS
- 8.2.3. AIR FREIGHT LOGISTICS
  - 8.2.3.1. MARKET FORECAST FIGURE
  - 8.2.3.2. SEGMENT ANALYSIS
8.3. MONITORING COMPONENTS
- 8.3.1. HARDWARE
  - 8.3.1.1. SENSORS
  - 8.3.1.1.1. MARKET FORECAST FIGURE
  - 8.3.1.1.2. SEGMENT ANALYSIS
  - 8.3.1.2. RFID DEVICES
  - 8.3.1.2.1. MARKET FORECAST FIGURE
  - 8.3.1.2.2. SEGMENT ANALYSIS
  - 8.3.1.3. TELEMATICS
  - 8.3.1.3.1. MARKET FORECAST FIGURE
  - 8.3.1.3.2. SEGMENT ANALYSIS
  - 8.3.1.4. NETWORKING DEVICES
  - 8.3.1.4.1. MARKET FORECAST FIGURE
  - 8.3.1.4.2. SEGMENT ANALYSIS
- 8.3.2. SOFTWARE
  - 8.3.2.1. MARKET FORECAST FIGURE
  - 8.3.2.2. SEGMENT ANALYSIS

9. COMPETITIVE LANDSCAPE

9.1. KEY STRATEGIC DEVELOPMENTS
- 9.1.1. MERGERS & ACQUISITIONS
- 9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
- 9.1.3. PARTNERSHIPS & AGREEMENTS
- 9.1.4. BUSINESS EXPANSIONS & DIVESTITURES
9.2. COMPANY PROFILES
- 9.2.1. AGILITY LOGISTICS
  - 9.2.1.1. COMPANY OVERVIEW
  - 9.2.1.2. PRODUCT PORTFOLIO
  - 9.2.1.3. STRENGTHS & CHALLENGES
- 9.2.2. AP MOLLER - MAERSK
  - 9.2.2.1. COMPANY OVERVIEW
  - 9.2.2.2. PRODUCT PORTFOLIO
  - 9.2.2.3. STRENGTHS & CHALLENGES
- 9.2.3. CARDINAL HEALTH
  - 9.2.3.1. COMPANY OVERVIEW
  - 9.2.3.2. PRODUCT PORTFOLIO
  - 9.2.3.3. STRENGTHS & CHALLENGES
- 9.2.4. CENCORA (AMERISOURCEBERGEN)
  - 9.2.4.1. COMPANY OVERVIEW
  - 9.2.4.2. PRODUCT PORTFOLIO
  - 9.2.4.3. STRENGTHS & CHALLENGES
- 9.2.5. CEVA LOGISTICS
  - 9.2.5.1. COMPANY OVERVIEW
  - 9.2.5.2. PRODUCT PORTFOLIO
  - 9.2.5.3. STRENGTHS & CHALLENGES
- 9.2.6. DB SCHENKER
  - 9.2.6.1. COMPANY OVERVIEW
  - 9.2.6.2. PRODUCT PORTFOLIO
  - 9.2.6.3. STRENGTHS & CHALLENGES
- 9.2.7. DEUTSCHE POST AG
  - 9.2.7.1. COMPANY OVERVIEW
  - 9.2.7.2. PRODUCT PORTFOLIO
  - 9.2.7.3. STRENGTHS & CHALLENGES
- 9.2.8. DSV
  - 9.2.8.1. COMPANY OVERVIEW
  - 9.2.8.2. PRODUCT PORTFOLIO
  - 9.2.8.3. STRENGTHS & CHALLENGES
- 9.2.9. FEDEX
  - 9.2.9.1. COMPANY OVERVIEW
  - 9.2.9.2. PRODUCT PORTFOLIO
  - 9.2.9.3. STRENGTHS & CHALLENGES
- 9.2.10. KUEHNE + NAGEL
  - 9.2.10.1. COMPANY OVERVIEW
  - 9.2.10.2. PRODUCT PORTFOLIO
  - 9.2.10.3. STRENGTHS & CHALLENGES

Product Code: 85226

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - PHARMACEUTICAL LOGISTICS
TABLE 2: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 3: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY PRODUCT, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 4: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY THERAPY AREA, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY THERAPY AREA, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 6: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY TYPE, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 8: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY COMPONENT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 9: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY COMPONENT, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 10: UNITED STATES STORAGE MARKET, BY SERVICE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 11: UNITED STATES STORAGE MARKET, BY SERVICE, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 12: UNITED STATES TRANSPORTATION MARKET, BY SERVICE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 13: UNITED STATES TRANSPORTATION MARKET, BY SERVICE, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 14: UNITED STATES MONITORING COMPONENTS MARKET, BY SERVICE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 15: UNITED STATES MONITORING COMPONENTS MARKET, BY SERVICE, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 16: UNITED STATES HARDWARE MARKET, BY HARDWARE TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 17: UNITED STATES HARDWARE MARKET, BY HARDWARE TYPE, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 18: LIST OF MERGERS & ACQUISITIONS
TABLE 19: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 20: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 21: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
FIGURE 3: GROWTH PROSPECT MAPPING FOR UNITED STATES
FIGURE 4: MARKET CONCENTRATION ANALYSIS
FIGURE 5: VALUE CHAIN ANALYSIS
FIGURE 6: KEY BUYING CRITERIA
FIGURE 7: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2023
FIGURE 8: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY BRANDED DRUGS, 2024-2032 (IN $ MILLION)
FIGURE 9: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY GENERIC DRUGS, 2024-2032 (IN $ MILLION)
FIGURE 10: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY OTC, 2024-2032 (IN $ MILLION)
FIGURE 11: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, GROWTH POTENTIAL, BY THERAPY AREA, IN 2023
FIGURE 12: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY COMMUNICABLE DISEASES, 2024-2032 (IN $ MILLION)
FIGURE 13: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY ONCOLOGY, 2024-2032 (IN $ MILLION)
FIGURE 14: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY DIABETES, 2024-2032 (IN $ MILLION)
FIGURE 15: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY CARDIOVASCULAR DISEASES, 2024-2032 (IN $ MILLION)
FIGURE 16: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY AUTOIMMUNE DISEASES, 2024-2032 (IN $ MILLION)
FIGURE 17: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY NEUROLOGICAL DISORDERS, 2024-2032 (IN $ MILLION)
FIGURE 18: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY PAIN MANAGEMENT, 2024-2032 (IN $ MILLION)
FIGURE 19: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY RESPIRATORY DISEASES, 2024-2032 (IN $ MILLION)
FIGURE 20: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY OTHER THERAPY AREAS, 2024-2032 (IN $ MILLION)
FIGURE 21: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, GROWTH POTENTIAL, BY TYPE, IN 2023
FIGURE 22: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY NON-COLD CHAIN LOGISTICS, 2024-2032 (IN $ MILLION)
FIGURE 23: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY COLD CHAIN LOGISTICS, 2024-2032 (IN $ MILLION)
FIGURE 24: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, GROWTH POTENTIAL, BY COMPONENT, IN 2023
FIGURE 25: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY STORAGE, 2024-2032 (IN $ MILLION)
FIGURE 26: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY WAREHOUSE, 2024-2032 (IN $ MILLION)
FIGURE 27: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY REFRIGERATED CONTAINERS, 2024-2032 (IN $ MILLION)
FIGURE 28: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY TRANSPORTATION, 2024-2032 (IN $ MILLION)
FIGURE 29: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY OVERLAND LOGISTICS, 2024-2032 (IN $ MILLION)
FIGURE 30: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY SEA FREIGHT LOGISTICS, 2024-2032 (IN $ MILLION)
FIGURE 31: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY AIR FREIGHT LOGISTICS, 2024-2032 (IN $ MILLION)
FIGURE 32: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY MONITORING COMPONENTS, 2024-2032 (IN $ MILLION)
FIGURE 33: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY HARDWARE, 2024-2032 (IN $ MILLION)
FIGURE 34: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY SENSORS, 2024-2032 (IN $ MILLION)
FIGURE 35: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY RFID DEVICES, 2024-2032 (IN $ MILLION)
FIGURE 36: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY TELEMATICS, 2024-2032 (IN $ MILLION)
FIGURE 37: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY NETWORKING DEVICES, 2024-2032 (IN $ MILLION)
FIGURE 38: UNITED STATES PHARMACEUTICAL LOGISTICS MARKET, BY SOFTWARE, 2024-2032 (IN $ MILLION)